AMIX
Autonomix Medical·NASDAQ
--
--(--)
--
--(--)
AMIX fundamentals
During Q3 2026, Autonomix Medical (AMIX) reported revenue of --, a YoY change of 0.00%. Net income was -3.26M, a YoY change of -20.24%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | Q1,2026 | Q2,2026 | Q3,2026 | TTM |
|---|
Start Date | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 | -- |
Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 544.00K -- | 657.00K -- | 871.00K -- | 5.82M -- | 2.92M +437.50% | 2.42M +267.73% | 2.75M +216.07% | 2.84M -51.27% | 2.75M -6.05% | 3.25M +34.60% | 3.42M +24.26% | 7.53M +165.66% | 3.34M +21.70% | 17.55M -- |
Selling, General and Administrative Expenses | 345.00K -- | 250.00K -- | 503.00K -- | 793.00K -- | 2.24M +548.41% | 1.72M +587.20% | 1.80M +257.65% | 1.66M +109.58% | 1.70M -23.87% | 1.70M -1.11% | 1.83M +1.61% | 5.17M +210.89% | 1.62M -4.93% | 10.31M -- |
General and Administrative Expenses | -- -- | 1.25M -- | -- -- | 793.00K -- | 2.24M -- | 1.72M +37.99% | 1.80M -- | 1.66M +109.58% | 1.70M -23.87% | 1.70M -1.11% | 1.83M +1.61% | 5.17M +210.89% | 1.62M -4.93% | 10.31M -- |
Research and Development Expenses | 199.00K -- | 407.00K -- | 368.00K -- | 471.00K -- | 687.00K +245.23% | 698.00K +71.50% | 954.00K +159.24% | 1.17M +149.26% | 1.04M +51.97% | 1.55M +122.49% | 1.59M +66.98% | 2.37M +101.62% | 1.72M +65.13% | 7.24M -- |
Other Operating Expenses | -- -- | 0 -- | -- -- | 4.56M -- | 0 -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -544.00K -- | -657.00K -- | -871.00K -- | -5.82M -- | -2.92M -437.50% | -2.42M -267.73% | -2.75M -216.07% | -2.84M +51.27% | -2.75M +6.05% | -3.25M -34.60% | -3.42M -24.26% | -7.53M -165.66% | -3.34M -21.70% | -17.55M -- |
Non-Operating Income (Loss) | -- -- | 0 -- | 6.00K -- | -220.00K -- | -189.00K -- | -2.99M -- | 54.00K +800.00% | 29.00K +113.18% | 35.00K +118.52% | 61.00K +102.04% | 84.00K +55.56% | 83.00K +186.21% | 82.00K +134.29% | 310.00K -- |
Gain (Loss) on Change in Fair Value | -- -- | 0 -- | -- -- | -239.00K -- | -179.00K -- | -3.03M -- | -- -- | -- -- | -- -- | 0 +100.00% | -- -- | -- -- | -- -- | -- -- |
Net Interest Expense | -- -- | 0 -- | -6.00K -- | -19.00K -- | 10.00K -- | -34.00K -- | -54.00K -800.00% | -29.00K -52.63% | -35.00K -450.00% | -61.00K -79.41% | -84.00K -55.56% | -83.00K -186.21% | -82.00K -134.29% | -310.00K -- |
Interest Expense | -- -- | 0 -- | -- -- | 0 -- | 33.00K -- | 46.00K -- | 41.00K -- | 43.00K -- | 45.00K +36.36% | 46.00K -- | 0 -100.00% | 0 -100.00% | 0 -100.00% | 46.00K -- |
Interest Income | -- -- | 0 -- | 6.00K -- | 19.00K -- | 23.00K -- | 80.00K -- | 95.00K +1483.33% | 72.00K +278.95% | 80.00K +247.83% | 107.00K +33.75% | 84.00K -11.58% | 83.00K +15.28% | 82.00K +2.50% | 356.00K -- |
Pretax Income From Continuing Operations | -544.00K -- | -657.00K -- | -865.00K -- | -6.04M -- | -3.11M -472.24% | -5.41M -723.14% | -2.70M -212.02% | -2.81M +53.53% | -2.71M +12.88% | -3.19M +40.99% | -3.34M -23.64% | -7.45M -165.44% | -3.26M -20.24% | -17.24M -- |
Income Tax Expense | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- |
Net Income | -544.00K -- | -657.00K -- | -865.00K -- | -6.04M -- | -3.11M -472.24% | -5.41M -723.14% | -2.70M -212.02% | -2.81M +53.53% | -2.71M +12.88% | -3.19M +40.99% | -3.34M -23.64% | -7.45M -165.44% | -3.26M -20.24% | -17.24M -- |
Net Income Attributable to Owners of the Company | -544.00K -- | -657.00K -- | -865.00K -- | -6.04M -- | -3.11M -472.24% | -5.41M -723.14% | -2.70M -212.02% | -2.81M +53.53% | -2.71M +12.88% | -3.19M +40.99% | -3.34M -23.64% | -7.45M -165.44% | -3.26M -20.24% | -17.24M -- |
Net Income Attributable to Common Stockholders | -544.00K -- | -657.00K -- | -865.00K -- | -6.04M -- | -3.11M -472.24% | -5.41M -723.14% | -2.70M -212.02% | -2.81M +53.53% | -2.71M +12.88% | -3.19M +40.99% | -3.34M -23.64% | -7.45M -165.44% | -3.26M -20.24% | -17.24M -- |
Other Comprehensive Income | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -1.99M -- | -- -- | -6.04M -- | -3.11M -- | -5.41M -171.76% | -2.70M -- | -- -- | -- -- | -11.41M -110.98% | -3.34M -23.64% | -- -- | -- -- | -- -- |
Basic EPS | -0.05 -- | -- -- | -0.07 -- | -8.78 -- | -3.07 -6040.00% | -0.29 -- | -2.2 -3042.86% | -2.27 +74.15% | -1.46 +52.44% | -1.28 -341.38% | -1.07 +51.36% | -1.38 +39.21% | -0.36 +75.34% | -4.09 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -8.78 -- | -3.07 -- | -- -- | -2.2 -- | -2.27 +74.15% | -1.46 +52.44% | -- -- | -1.07 +51.36% | -1.38 +39.21% | -0.36 +75.34% | -- -- |
Diluted EPS | -0.05 -- | -- -- | -0.07 -- | -8.78 -- | -3.07 -6040.00% | -- -- | -2.2 -3042.86% | -2.27 +74.15% | -1.46 +52.44% | -- -- | -1.07 +51.36% | -1.38 +39.21% | -0.36 +75.34% | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -8.78 -- | -3.07 -- | -- -- | -2.2 -- | -2.27 +74.15% | -1.46 +52.44% | -- -- | -1.07 +51.36% | -1.38 +39.21% | -0.36 +75.34% | -- -- |
You can ask Aime
What were the key takeaways from Autonomix Medical's earnings call?What is the revenue and EPS growth rate for Autonomix Medical year over year?What is Autonomix Medical's latest dividend and current dividend yield?What is Autonomix Medical's gross profit margin?Did Autonomix Medical beat or miss consensus estimates last quarter?What is the market's earnings forecast for Autonomix Medical next quarter?What does Autonomix Medical do and what are its main business segments?What factors drove the changes in Autonomix Medical's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
